2.57
price down icon3.38%   -0.09
 
loading
Medicus Pharma Ltd stock is traded at $2.57, with a volume of 414.05K. It is down -3.38% in the last 24 hours and down -61.81% over the past month. Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.66
Open:
$2.73
24h Volume:
414.05K
Relative Volume:
2.08
Market Cap:
$47.00M
Revenue:
-
Net Income/Loss:
$-11.73M
P/E Ratio:
-1.8588
EPS:
-1.3826
Net Cash Flow:
$-10.37M
1W Performance:
-12.88%
1M Performance:
-61.81%
6M Performance:
-2.65%
1Y Performance:
+0.00%
1-Day Range:
Value
$2.44
$2.99
1-Week Range:
Value
$2.44
$2.99
52-Week Range:
Value
$1.80
$8.94

Medicus Pharma Ltd Stock (MDCX) Company Profile

Name
Name
Medicus Pharma Ltd
Name
Phone
610-540-7515
Name
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Name
Employee
12
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MDCX's Discussions on Twitter

Compare MDCX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - General icon
MDCX
Medicus Pharma Ltd
2.57 47.00M 0 -11.73M -10.37M -1.3826
Drug Manufacturers - General icon
LLY
Lilly Eli Co
791.24 724.64B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
152.38 376.43B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
74.34 352.49B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
ABBV
Abbvie Inc
185.48 334.73B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
116.41 234.21B 53.22B 12.86B 14.85B 6.39

Medicus Pharma Ltd Stock (MDCX) Latest News

pulisher
Jun 13, 2025

Medicus Pharma targets horse cancer with new trial – ICYMI - Proactive financial news

Jun 13, 2025
pulisher
Jun 12, 2025

Medicus Pharma to present at BIO 2025 - Proactive financial news

Jun 12, 2025
pulisher
Jun 12, 2025

Medicus Pharma to Present at Bio Convention and Expand Cancer Treatment Portfolio - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Medicus Pharma Ltd. to Present at 2025 Bio International Convention - Newsfile

Jun 12, 2025
pulisher
Jun 12, 2025

BMO Launches Human Capital Factor US Equity ETF - The Globe and Mail

Jun 12, 2025
pulisher
Jun 12, 2025

If I Could Only Buy and Hold a Single Stock, This Would Be It. - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong - The Globe and Mail

Jun 11, 2025
pulisher
Jun 11, 2025

Medicus Pharma Ltd. (NASDAQ: MDCX) Strategically Positions Itself in the Rapidly Growing Biotech Market - citybuzz -

Jun 11, 2025
pulisher
Jun 10, 2025

Medicus Pharma submits development plan for novel Equine Cancer treatment - Proactive financial news

Jun 10, 2025
pulisher
Jun 10, 2025

Medicus Pharma’s (MDCX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotech Market - openPR.com

Jun 10, 2025
pulisher
Jun 10, 2025

Should You Invest $1,000 in Verizon Today? - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Medicus Pharma prices $7 million share offering - MSN

Jun 10, 2025
pulisher
Jun 09, 2025

Medicus Pharma advances cancer patch for horses By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Medicus Pharma submits FDA plan to develop microneedle-based treatment for skin cancer in horses - Proactive financial news

Jun 09, 2025
pulisher
Jun 09, 2025

Is Newmont Stock Outperforming the Nasdaq? - The Globe and Mail

Jun 09, 2025
pulisher
Jun 09, 2025

Medicus Pharma Submits FDA Plan for Novel Equine Cancer Treatment - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Medicus Pharma advances cancer patch for horses - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

5 Monster Stocks to Hold for the Next 10 Years - The Globe and Mail

Jun 09, 2025
pulisher
Jun 08, 2025

Certain Common Stock of Medicus Pharma Ltd. are subject to a Lock-Up Agreement Ending on 9-JUN-2025. - marketscreener.com

Jun 08, 2025
pulisher
Jun 06, 2025

Eli Lilly Stock (LLY) Gets Multiple Wall Street Downgrades - The Globe and Mail

Jun 06, 2025
pulisher
Jun 05, 2025

How major US stock indexes fared Thursday, 6/5/2025 - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

Why Shares of Robinhood Are Surging This Week - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

The Golden Retracement Keeps Sending Wheat Lower & New Video! - The Globe and Mail

Jun 04, 2025
pulisher
Jun 04, 2025

Why Wolfspeed Stock Is Soaring Today - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

Multiple insider buying at BuildDirect.com (BILD) - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

Are Options Traders Betting on a Big Move in Autodesk Stock? - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

Medicus Pharma completes $7 million public offering By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Why Broadcom Stock Blew Past the Market on Monday - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Medicus Pharma completes $7 million public offering - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Medicus Pharma Secures $7 Million for Cancer Treatment Trials - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering - Newsfile

Jun 02, 2025
pulisher
Jun 02, 2025

Medicus Pharma closes $7M public offering - Proactive financial news

Jun 02, 2025
pulisher
Jun 01, 2025

2 Nasdaq Stocks to Buy in June - The Globe and Mail

Jun 01, 2025
pulisher
May 31, 2025

Biotech Stocks Plummet As Public Offerings Shake Market - Finimize

May 31, 2025
pulisher
May 31, 2025

Health Sector Experiences Mixed Fortunes As Trials And Stock Moves Shake Up Market - Finimize

May 31, 2025
pulisher
May 31, 2025

Small cap wrap: ReconAfrica, Charbone Hydrogen, Medicus Pharma.... - Proactive financial news

May 31, 2025
pulisher
May 30, 2025

Sector Update: Health Care - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Form 424B4 Medicus Pharma Ltd. - StreetInsider

May 30, 2025
pulisher
May 30, 2025

Medicus Pharma Prices $7 Million Public Offering; Shares Fall - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Medicus Pharma unveils pricing of $7M public offering - Proactive financial news

May 30, 2025
pulisher
May 30, 2025

Medicus Pharma (NASDAQ:MDCX) Upgraded at Wall Street Zen - Defense World

May 30, 2025
pulisher
May 30, 2025

Medicus Pharma’s (MDCX) Buy Rating Reaffirmed at D. Boral Capital - Defense World

May 30, 2025
pulisher
May 29, 2025

Medicus Pharma Ltd. Launches $7 Million Public Offering to Advance Cancer Treatment Trials - TipRanks

May 29, 2025
pulisher
May 29, 2025

Medicus Pharma Secures $7M Funding to Advance Revolutionary Skin Cancer Patch Through Phase 2 Trials - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering - Newsfile

May 29, 2025
pulisher
May 28, 2025

Definity Financial Corporation Announces Increased Size of Previously Announced Private Placements of Common Shares to $385 million - The Globe and Mail

May 28, 2025
pulisher
May 27, 2025

Medicus Pharma Files For Resale From Time To Time Of Up To 3.7 Mln Common Shares - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

Definity Financial Corporation Announces Agreement to Acquire Canadian Operations of Travelers for $3.3 billion and Concurrent $351 million Private Placements of Common Shares - The Globe and Mail

May 27, 2025

Medicus Pharma Ltd Stock (MDCX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_general SNY
$48.22
price down icon 2.41%
$108.00
price down icon 2.55%
drug_manufacturers_general PFE
$24.00
price down icon 1.64%
$290.05
price down icon 1.86%
drug_manufacturers_general MRK
$78.28
price down icon 3.31%
drug_manufacturers_general NVS
$116.41
price down icon 1.42%
Cap:     |  Volume (24h):